These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

740 related articles for article (PubMed ID: 15356098)

  • 1. Rat NKp46 activates natural killer cell cytotoxicity and is associated with FcepsilonRIgamma and CD3zeta.
    Westgaard IH; Berg SF; Vaage JT; Wang LL; Yokoyama WM; Dissen E; Fossum S
    J Leukoc Biol; 2004 Dec; 76(6):1200-6. PubMed ID: 15356098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD59 is physically and functionally associated with natural cytotoxicity receptors and activates human NK cell-mediated cytotoxicity.
    Marcenaro E; Augugliaro R; Falco M; Castriconi R; Parolini S; Sivori S; Romeo E; Millo R; Moretta L; Bottino C; Moretta A
    Eur J Immunol; 2003 Dec; 33(12):3367-76. PubMed ID: 14635045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulation of murine natural killer (NK) cells by a monoclonal antibody specific for the NK1.1 antigen. IL-2-activated NK cells possess additional specific stimulation pathways.
    Karlhofer FM; Yokoyama WM
    J Immunol; 1991 May; 146(10):3662-73. PubMed ID: 2026886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure/function relationship of activating Ly-49D and inhibitory Ly-49G2 NK receptors.
    Ortaldo JR; Winkler-Pickett R; Willette-Brown J; Wange RL; Anderson SK; Palumbo GJ; Mason LH; McVicar DW
    J Immunol; 1999 Nov; 163(10):5269-77. PubMed ID: 10553049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural killing of xenogeneic cells mediated by the mouse Ly-49D receptor.
    Nakamura MC; Naper C; Niemi EC; Spusta SC; Rolstad B; Butcher GW; Seaman WE; Ryan JC
    J Immunol; 1999 Nov; 163(9):4694-700. PubMed ID: 10528166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NKR-P1, an activating molecule on rat natural killer cells, stimulates phosphoinositide turnover and a rise in intracellular calcium.
    Ryan JC; Niemi EC; Goldfien RD; Hiserodt JC; Seaman WE
    J Immunol; 1991 Nov; 147(9):3244-50. PubMed ID: 1919012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative analysis of human NK cell activation induced by NKG2D and natural cytotoxicity receptors.
    André P; Castriconi R; Espéli M; Anfossi N; Juarez T; Hue S; Conway H; Romagné F; Dondero A; Nanni M; Caillat-Zucman S; Raulet DH; Bottino C; Vivier E; Moretta A; Paul P
    Eur J Immunol; 2004 Apr; 34(4):961-71. PubMed ID: 15048706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of the amino acid sequence motif for conventional PKC-mediated regulation of NKp46 surface expression.
    Kim HR; Chwae YJ; Kim J
    Scand J Immunol; 2010 Jun; 71(6):413-9. PubMed ID: 20500693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Receptors and lytic mediators regulating anti-tumor activity by the leukemic killer T cell line TALL-104.
    Brando C; Mukhopadhyay S; Kovacs E; Medina R; Patel P; Catina TL; Campbell KS; Santoli D
    J Leukoc Biol; 2005 Aug; 78(2):359-71. PubMed ID: 15937142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NKp46 and NKG2D receptor expression in NK cells with CD56dim and CD56bright phenotype: regulation by histamine and reactive oxygen species.
    Romero AI; Thorén FB; Brune M; Hellstrand K
    Br J Haematol; 2006 Jan; 132(1):91-8. PubMed ID: 16371024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced in vivo growth of lymphoma tumors in the absence of the NK-activating receptor NKp46/NCR1.
    Halfteck GG; Elboim M; Gur C; Achdout H; Ghadially H; Mandelboim O
    J Immunol; 2009 Feb; 182(4):2221-30. PubMed ID: 19201876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of cloned human natural killer cells via Fc gamma RIII.
    Werfel T; Uciechowski P; Tetteroo PA; Kurrle R; Deicher H; Schmidt RE
    J Immunol; 1989 Feb; 142(4):1102-6. PubMed ID: 2464637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The natural cytotoxicity receptor NKp46 is dispensable for IL-22-mediated innate intestinal immune defense against Citrobacter rodentium.
    Satoh-Takayama N; Dumoutier L; Lesjean-Pottier S; Ribeiro VS; Mandelboim O; Renauld JC; Vosshenrich CA; Di Santo JP
    J Immunol; 2009 Nov; 183(10):6579-87. PubMed ID: 19846871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A "chimeric" C57l-derived Ly49 inhibitory receptor resembling the Ly49D activation receptor.
    Mehta IK; Smith HR; Wang J; Margulies DH; Yokoyama WM
    Cell Immunol; 2001 Apr; 209(1):29-41. PubMed ID: 11414734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of cytolytic activity in CD3- and CD3+ killer cell clones by monoclonal antibodies (anti-CD16, anti-CD2, anti-CD3) depends on subclass specificity of target cell IgG-FcR.
    van de Griend RJ; Bolhuis RL; Stoter G; Roozemond RC
    J Immunol; 1987 May; 138(10):3137-44. PubMed ID: 2952709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The requirement for DNAM-1, NKG2D, and NKp46 in the natural killer cell-mediated killing of myeloma cells.
    El-Sherbiny YM; Meade JL; Holmes TD; McGonagle D; Mackie SL; Morgan AW; Cook G; Feyler S; Richards SJ; Davies FE; Morgan GJ; Cook GP
    Cancer Res; 2007 Sep; 67(18):8444-9. PubMed ID: 17875681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Visualization of effective tumor targeting by CD8+ natural killer T cells redirected with bispecific antibody F(ab')(2)HER2xCD3.
    Scheffold C; Kornacker M; Scheffold YC; Contag CH; Negrin RS
    Cancer Res; 2002 Oct; 62(20):5785-91. PubMed ID: 12384539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vital involvement of a natural killer cell activation receptor in resistance to viral infection.
    Brown MG; Dokun AO; Heusel JW; Smith HR; Beckman DL; Blattenberger EA; Dubbelde CE; Stone LR; Scalzo AA; Yokoyama WM
    Science; 2001 May; 292(5518):934-7. PubMed ID: 11340207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Murine B-cell leukemia lymphoma (BCL1) cells as a target for NK cell-mediated immunotherapy.
    Weiss L; Reich S; Mandelboim O; Slavin S
    Bone Marrow Transplant; 2004 Jun; 33(11):1137-41. PubMed ID: 15077128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular characterization of the novel rat NK receptor 1C7.
    Bäckman-Petersson E; Miller JR; Hollyoake M; Aguado B; Butcher GW
    Eur J Immunol; 2003 Feb; 33(2):342-51. PubMed ID: 12548565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.